InsidersTradesSigma
Seelos Therapeutics, INC. Stock: price and insider trades · United States · SEC (Form 4)
Track the Seelos Therapeutics, INC. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Operating in the Health Care sector, Seelos Therapeutics, INC. has logged 9 reports. Market capitalisation: €58. The latest transaction was reported on 1 March 2024 (Attribution). Among the most active insiders: Golembiewski Michael Joseph. Every trade is openly available.
9
Insider Decl.
0
Thresholds
€263,195
5 ops.
Buy Volume
·
0 ops.
Sell Volume
43Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 1 March 2024
Declarations9 total
417 shares@ US$1.0970.4% of flowCommon StockSEC:0001104659-24-030070:0
83,000 shares@ US$1.207578.2% of flowCommon StockSEC:0001104659-23-122841:0
Ideal exit: 26 Aug 2024 (T+270)
12,500 shares@ US$0.6186.1% of flowCommon StockSEC:0001104659-23-097765:0
12,500 shares@ US$0.6726.8% of flowCommon StockSEC:0001104659-23-027915:0
16,000 shares@ US$0.6118100.0% of flowCommon StockSEC:0001136261-22-000249:0
Ideal exit: 26 Feb 2023 (T+270)
35,000 shares@ US$0.599100.0% of flowCommon StockSEC:0001136261-22-000247:0
Ideal exit: 20 Feb 2023 (T+270)
12,500 shares@ US$0.901100.0% of flowCommon StockSEC:0001136261-22-000155:0
9 of 9 declarations